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Objective: To evaluate the diagnostic accuracy of multidetector 64-slice computed tomography
(MDCT) in the diagnosis and differentiation of benign and malignant ovarian masses using
histopathology and surgical findings as the gold standard.
Material and methods: This study was conducted in Aga Khan University Hospital,
Karachi, Pakistan. Data was reviewed retrospectively from 1 November 2008 to 12 December
2009. One hundred patients found to have ovarian masses on CT scan were included in the
study. CT scan was performed in all these patients after administration of oral and IV contrast.
Ovarian masses were classified as benign and malignant on scan findings. Imaging findings
were compared with histopathologic results and surgical findings. Sensitivity, specificity,
positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of
MDCT were calculated.
Results: MDCT was found to have 97% sensitivity, 91% specificity, and an accuracy of 96%
in the differentiation of benign and malignant ovarian masses, while PPV and NPV were 97%
and 91%, respectively.
Conclusion: MDCT imaging offers a safe, accurate and noninvasive modality to differentiate
between benign and malignant ovarian masses.
Keywords: ovarian masses, surgery, MDCT

Adnexal masses can be benign or malignant and the benign masses greatly outnumber
malignant ones.1 Ovarian cancer is one of the most common gynecological malignancies
and cause of death in the western world and the USA. It is also one of the most prevalent
cancers in Pakistan.2,3 Precise characterization of an adnexal lesion is important as it
dictates further management; hence, the role of radiology is very important. Until the
last decade, exploratory laparotomy was used for the diagnosis and staging of adnexal
masses, however, modern imaging techniques have demonstrated similar accuracy in
the diagnosing and staging of ovarian carcinoma. Ultrasound is the first line modality
to evaluate adnexal pathologies, however, most of the time it is unable to differentiate
between benign and malignant lesions and the extent of disease in malignant cases.
Sometimes when conventional ultrasound reveals complex morphology then other
diagnostic tools can be used such as color Doppler and functional tumor vessel
properties, serum CA 125 levels, nuclear magnetic resonance imaging, and in some
cases laparoscopy.4 CT is the investigation of choice in planning further management
in patients believed to have metastatic disease. Multidetector computed tomography
(MDCT) also allows comprehensive evaluation of primary tumour and the site of
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peritoneal metastasis and lymphadenopathy. On CT scan,
masses can be characterized and features pertaining to
benignity and malignancy can be observed. Local data
regarding ovarian mass evaluation by MDCT are scarce.
Therefore, the objective of this study was to evaluate the
diagnostic accuracy of MDCT in our local population to
differentiate between benign and malignant ovarian masses
and to compare the findings with histopathologic results
and surgery.

Material and methods
We retrospectively reviewed the preoperative MDCT
findings of 100 ovarian tumors classified as either benign or
malignant at subsequent surgical resection. Most patients
had been referred for an asymptomatic adnexal mass. One
had been referred because of pelvic pain, and two had been
referred because of a previous ovarian cyst. The mean
age of the patients was 50 ± 17 years with an age range
from 19 to 82 years. Evaluators were blinded with surgical
findings. We excluded patients with bilateral ovarian masses,
concomitant carcinoma breast with metastatic disease,
postoperative patients, those who were diagnosed as having
malignant masses on ultrasound, and those in which origin
from ovary was uncertain.
Patients were given oral nonionic contrast 2 hours before
scanning. All scans were performed by MDCT on a 64 row CT
scanner. The patients were scanned from the base of the lungs
to the symphysis pubis after IV injection of 80–100 mL of
nonionic contrast in portovenous phase with a scanning delay
of 60–90s. Image slices of 10-mm-thickness were obtained
followed by reconstruction in sagittal and coronal planes.
MDCT images were reviewed by a consultant radiologist with
experience in gynecological CT imaging. CT findings used
to diagnose malignancy were: diameter greater than 4 cm,
cystic-solid mass, necrosis in a solid lesion, cystic lesion with
thick, irregular walls or septa, and/or with papillary projections
(Figure 1). Presence of ascites, peritoneal metastases,
and lymphadenopathy were used to confirm malignancy.
In addition, the presence of omental cake, peritoneal
deposits, mesenteric deposits, and lymphadenopathy were
also documented. Benign lesions have diameters less than
4 cm and well defined margins, without evidence of local or
distant spread. Cystic lesions are unilocular, and have thin
walls with minimal septations, and the absence of papillary
projection. Statistical analysis was performed using SPSS
(v.16; SPSS Inc; Chicago, IL). The sensitivity, specificity,
positive predictive value (PPV), negative predictive value
(NPV), and diagnostic accuracy were calculated.
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Figure 1 Fifty-year-old female presented with a palpable mass in the lower abdomen.
Oral and IV contrast enhanced CT revealed 10 cm heterogeneously enhancing solid
mass arising from right adnexa.

Results
Out of the 100 ovarian lesions, 76 were read by MDCT as
malignant and 24 as benign lesions. On later histopathological
findings, 76 of the 100 lesions had malignant lesions while
24 were benign. In the benign group, patients’ ages ranged
from 19–82 years (mean, 23.5 years). In the malignant group,
patients’ ages ranged from 48–72 years (mean, 60 years).
Malignant lesions included papillary carcinoma (n = 18),
malignant mullerian tumor (n = 12), adenocarcinomas (n = 32),
and endometrioid carcinomas (n = 14). Benign lesions were
simple ovarian cyst (n = 2), corpus luteal cyst (n = 2), benign
cystadenoma (n = 4), dermoid (n = 2), teratomas (n = 2), and
endometriomas (n = 12) (See Tables 1 and 2).
Table 1 Final diagnosis: benign lesions n = 24
Multidetector computed
tomography findings

Histopathology/surgery
findings

Thin walled cyst, less than 4 cm in size
Thin walled cyst, less than 4 cm in size
Thin walled cyst, less than 4 cm in size,
except in one case which was a solid lesion
of less than 4 cm in size with necrosis
Solid lesion, thick wall, calcifications
Thin walled cyst of less than 4 cm
in size, few areas of hemorrhage
Solid well defined lesion, fat density,
except one which had central necrosis
and no fat density

Simple ovarian cyst n = 2
Corpus luteal cyst n = 2
Benign cystadenoma n = 4

Dermoid cyst n = 2
Endometrioma n = 12
Teratoma n = 2
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Table 2 Final diagnosis: malignant lesions n = 76
Multidetector computed
tomography findings

Histopathology/surgery
findings

Thick walled, large solid cum
cystic mass, ascites, lymphnodes
Thick walled, large masses with
central necrosis
Large multiseptated, solid cum cystic,
ascites except one which was a large
cyst with thin internal septations
Large solid masses, lymph nodes,
omental thickening except one
which was less than 4 cm and had
well defined thin walls

Papillary carcinoma n = 18
Malignant mullerian n = 12
Adenocarcinoma n = 32

Endometriod carcinoma n = 14

There were two false positive cases: one on imaging
appeared as a solid lesion with necrosis and an adherent
fallopian tube; and the other one had an adjacent endometrioma
deposit on the broad ligament which we mistakenly identified
as a solid component. Both cases also had ascites as an
ancillary finding.
Similarly there were two false negative results: one which
we labeled as benign on the basis of its small size, ,4 cm, and
well defined wall, which was an endometrioid carcinoma; and
the other which we identified as a large simple cyst with thin
septations was found to be a mucinous cyst adenocarcinoma
via histopathology.
Thus, there were 74 true positives, 2 false positives,
22 true negative, and 2 false negative results reported on
MDCT based assessment. Overall, MDCT was found to have
97.3% sensitivity, 91.6% specificity, and an accuracy of 96%
in the differentiation of benign and malignant ovarian masses,
while PPV and NPV were 97.3% and 91.6%, respectively.

Discussion
In day-to-day practice, we come across many cases of
adnexal masses. Some of these turn out to be benign, some
borderline, and some malignant. When an ovarian mass is
detected, there are two major issues: to determine whether it
is benign or malignant, and then if it is malignant, to look for
the extent of disease.5,6 If the nature of the mass is adequately
determined on the image, then it saves the patient unnecessary
surgery and expense. Similarly if staging is accurately done
on imaging, again it becomes cost-effective and it helps in
further planning.7,8
However, we understand that surgery has a role in
definite diagnosis and the further characterization of masses.
Sometimes CT underestimates staging and pelvic examination
by a gynecologist and serum CA-125 are of limited value in
the diagnosis of pelvic masses and their sensitivity is often
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below 50%.8 The sensitivity of morphologic analysis with
ultrasound in predicting malignancy in ovarian tumors has
been shown to be 85%–97%, whereas its specificity ranges
from 56%–95%.9–11
Our results are comparable to previously published
international literature (Table 3).12–14 A meta-analysis conducted
by Kinkel et al described that CT shows sensitivity and specificity
of 81% and 87% respectively when used for indeterminate
masses seen on ultrasound.12 Similarly, Liu et al reported that
PET/CT scanner shows a sensitivity of 87% and specificity
of 100% for differentiating benign from malignant ovarian
cancers.14 Tsili et al also described in their study that MDCT
can categorize adnexal masses into benign and malignant in up
to 93% and 89% of the cases.13 Our study reported a sensitivity
and specificity of 97% and 91%, respectively.
CT appearances of ovarian masses vary widely and
accurate histologic characterization is not always possible.
Although tumor markers like CA-125, AFP, and HCG
are indicative of ovarian cancer and germ cell tumors
respectively, careful consideration inspite of the components
of the masses and evidence of malignant spread are useful
from a management aspect.15,16
Certain radiologic findings predominate for each type of
tumor; knowledge of these key features of ovarian tumors
may allow a specific diagnosis or substantial narrowing of
differential diagnosis.17–19 The image appearance of ovarian
tumors ranges from cystic to solid masses. Although tumors
have similar clinical and radiological findings, predominant
or specific key features are present in each type of ovarian
tumor.20–22
Our study shows high accuracy (96%), however, there
were two false positive and two false negative results. Lesions
characterized as benign have imaging characteristics similar
to benign lesions, ie, less than 4 cm in size, smooth walls
without thick septations, making evaluation of these tumors
difficult. Similarly, regarding false positive results, these
lesions have characteristics of malignant lesions, ie, solid
lesions with necrosis, infiltration to adjacent organs and
Table 3 Sensitivity and specificity of multidetector computed
tomography in differentiating benign from malignant adnexal
masses
Author

Sensitivity (%)

Specificity (%)

Kinkel et al12
Tsili et al13
Liu et al14
Mubarak et ala

81
90
87
97

87
88
100
91

Note: athe present study.
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the presence of ascites. These features make it difficult to
recognize on images, resulting in false positive and negative
results. Other possibilities include interpretation error or not
using reformatted images properly.
Our study has a few limitations besides the small number
of benign cases included in the sample. Only those patients
who were referred to MDCT scan were included, which
introduces bias. No interobserver agreement for MDCT
images evaluation was calculated.

Conclusion
MDCT is an excellent noninvasive modality to differentiate
adnexal masses from benign and malignant causes, and the
CT findings used to diagnose malignancy were: diameter
greater than 4 cm, cystic-solid mass, necrosis in a solid
lesion, cystic lesion with thick, irregular walls or septa,
and/or with papillary projections. The presence of ascites,
peritoneal metastases, and lymphadenopathy was also used
to confirm malignancy.
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